The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells

This publication has 44 references indexed in Scilit:

• High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin/IL-3 fusion protein
  Leukemia Research, 2001
• Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
  Blood, 2001
• Variable cytotoxicity of diphtheria toxin 388–granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells
  Experimental Hematology, 2000
• Urokinase receptor: a molecular organizer in cellular communication
  Current Opinion in Cell Biology, 2000
• How I treat older patients with AML
  Blood, 2000
• Expression and functional role of urokinase‐type plasminogen activator receptor in normal and acute leukaemic cells
  British Journal of Haematology, 1998
• Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells
  Journal of Biological Chemistry, 1997
• Expression of the Receptor for Urokinasetype Plasminogen Activator in Normal and Neoplastic Blood Cells and Hematopoietic Tissue
  American Journal of Clinical Pathology, 1994
• Structure—function relationships in the receptor for urokinase‐type plasminogen activator Comparison to other members of the Ly‐6 family and snake venom α‐neurotoxins
  FEBS Letters, 1994
• Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
  Trends in Pharmacological Sciences, 1994